Why is Welcure Drugs falling/rising?

As of 03-Jul, Welcure Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 12.90, which reflects a decrease of 0.67 or 4.94%. The stock has underperformed its sector today, with a notable drop of 5.42%. It has been on a downward trend for the last two days, accumulating a total decline of 9.66%. Despite this recent downturn, the stock has shown strong performance over the past year, boasting a remarkable return of 133.27%, significantly outpacing the market's return of 2.20%. Additionally, the company reported positive financial results in March, with net sales growing at an extraordinary rate and achieving record profits, which may have contributed to its previous gains.
In the broader market context, the stock's short-term performance over the past week indicates a decline of 5.43%, while the benchmark Sensex has only decreased by 0.62%. This suggests that the stock is underperforming relative to the broader market. However, the stock's year-to-date return of 10.54% still surpasses the benchmark's 6.53%, indicating that while it is currently facing challenges, it has had a strong performance overall in 2023. The rising investor participation, as evidenced by a significant increase in delivery volume, may suggest that there is still interest in the stock despite its recent price decline.